albendazol
Sign in to saveAlbendazole is a broad-spectrum antihelmintic and antiprotozoal agent of the benzimidazole type. It is used for the treatment of a variety of intestinal parasite infections, including ascariasis, pinworm infection, hookworm infection, trichuriasis, strongyloidiasis, taeniasis, clonorchiasis, opisthorchiasis, cutaneous larva migrans, giardiasis, and gnathostomiasis, among other diseases.
Key facts
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 477316402
- Drug.image
- Albendazole.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Albendazole-from-xtal-2007-3D-balls.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250
- Drug.tradename
- Albenza, others
- Drug.MedlinePlus
- a610019
- Drug.DailyMedID
- Albendazole
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- P02
- Drug.ATC_suffix
- CA03
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_UK
- POM
- Drug.legal_US
- Rx-only
via Wikipedia infobox
Research
8,754 papers- Albendazole.The Journal of antimicrobial chemotherapy · 1998
- Albendazole-Induced Liver Injury.American journal of therapeutics · 2021
- Albendazole.Indian pediatrics · 1993
- Praziquantel vs. albendazol for cysticercosis.Neurosurgery · 1988
- Therapy for neurocysticercosis.Expert review of neurotherapeutics · 2004
via PubMed
Article
18 sectionsContents
- Medical uses
- Ivermectin/albendazole
- Contraindications
- Side effects
- Pregnancy
- Overdose
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- History
- Society and culture
- Economics
- Brand names
- Research
- Veterinary use
- Meat
- References
Albendazole is a broad-spectrum antihelmintic and antiprotozoal agent of the benzimidazole type. It is used for the treatment of a variety of intestinal parasite infections, including ascariasis, pinworm infection, hookworm infection, trichuriasis, strongyloidiasis, taeniasis, clonorchiasis, opisthorchiasis, cutaneous larva migrans, giardiasis, and gnathostomiasis, among other diseases.
Common side effects include nausea, abdominal pain, and headache. Rare but potentially serious side effects include bone marrow suppression which usually improves on discontinuing the medication. Liver inflammation has been reported and those with prior liver problems are at greater risk. It is pregnancy category D in Australia, meaning it may cause harm if taken by pregnant women.